140 related articles for article (PubMed ID: 31393567)
1. Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older Subjects.
Pham H; Marathe CS; Phillips LK; Trahair LG; Hatzinikolas S; Huynh L; Wu T; Nauck MA; Rayner CK; Horowitz M; Jones KL
J Clin Endocrinol Metab; 2019 Dec; 104(12):6201-6206. PubMed ID: 31393567
[TBL] [Abstract][Full Text] [Related]
2. The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance.
Marathe CS; Pham H; Marathe JA; Trahair LG; Huynh L; Wu T; Phillips LK; Rayner CK; Nauck MA; Horowitz M; Jones KL
Acta Diabetol; 2020 May; 57(5):583-587. PubMed ID: 31848710
[TBL] [Abstract][Full Text] [Related]
3. Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea.
Matsumoto T; Harada N; Azuma M; Chihara Y; Murase K; Tachikawa R; Minami T; Hamada S; Tanizawa K; Inouchi M; Oga T; Mishima M; Chin K
Ann Am Thorac Soc; 2016 Aug; 13(8):1378-87. PubMed ID: 27104640
[TBL] [Abstract][Full Text] [Related]
4. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT.
Alssema M; Rijkelijkhuizen JM; Holst JJ; Teerlink T; Scheffer PG; Eekhoff EM; Gastaldelli A; Mari A; Hart LM; Nijpels G; Dekker JM
Eur J Endocrinol; 2013 Oct; 169(4):421-30. PubMed ID: 23864340
[TBL] [Abstract][Full Text] [Related]
5. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
6. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
7. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
[TBL] [Abstract][Full Text] [Related]
8. Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.
Gjesing AP; Ekstrøm CT; Eiberg H; Urhammer SA; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2012 May; 55(5):1338-45. PubMed ID: 22349073
[TBL] [Abstract][Full Text] [Related]
9. Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.
Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Yokoyama H; Haneda M
Front Endocrinol (Lausanne); 2020; 11():214. PubMed ID: 32390941
[No Abstract] [Full Text] [Related]
10. GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment.
Cira DK; Sari R; Ozdem S; Yilmaz N; Bozkurt S
Ann Pharmacother; 2017 Aug; 51(8):663-668. PubMed ID: 28452237
[TBL] [Abstract][Full Text] [Related]
11. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
12. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
[TBL] [Abstract][Full Text] [Related]
13. Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance.
Stinson SE; Fernández de Retana Alzola I; Brünner Hovendal ED; Lund MAV; Fonvig CE; Holm LA; Jonsson AE; Frithioff-Bøjsøe C; Christiansen M; Pedersen O; Ängquist L; Sørensen TIA; Holst JJ; Hartmann B; Holm JC; Hansen T
J Clin Endocrinol Metab; 2024 May; 109(6):1590-1600. PubMed ID: 38087928
[TBL] [Abstract][Full Text] [Related]
14. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
[TBL] [Abstract][Full Text] [Related]
15. Incretin secretion in humans is under the influence of cannabinoid receptors.
Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
[TBL] [Abstract][Full Text] [Related]
16. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
[TBL] [Abstract][Full Text] [Related]
17. The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study.
Stevens JE; Horowitz M; Deacon CF; Nauck M; Rayner CK; Jones KL
Aliment Pharmacol Ther; 2012 Aug; 36(4):379-90. PubMed ID: 22738299
[TBL] [Abstract][Full Text] [Related]
18. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
[TBL] [Abstract][Full Text] [Related]
20. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]